Cargando…

Diabetes and Obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and Insulin Resistance

Background: Diabetes and obesity are increasingly significant public health issues. The aim of this study was to evaluate the relationship between adipocytokines (leptin, ghrelin, and chemerin), inflammation (sVCAM1—soluble vascular adhesion molecule 1, sICAM1—soluble intercellular adhesion molecule...

Descripción completa

Detalles Bibliográficos
Autores principales: Sitar-Taut, Adela-Viviana, Coste, Sorina Cezara, Tarmure, Simina, Orasan, Olga Hilda, Fodor, Adriana, Negrean, Vasile, Pop, Dana, Zdrenghea, Dumitru, Login, Cezar, Tiperciuc, Brandusa, Cozma, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564772/
https://www.ncbi.nlm.nih.gov/pubmed/32858998
http://dx.doi.org/10.3390/jcm9092767
_version_ 1783595790271250432
author Sitar-Taut, Adela-Viviana
Coste, Sorina Cezara
Tarmure, Simina
Orasan, Olga Hilda
Fodor, Adriana
Negrean, Vasile
Pop, Dana
Zdrenghea, Dumitru
Login, Cezar
Tiperciuc, Brandusa
Cozma, Angela
author_facet Sitar-Taut, Adela-Viviana
Coste, Sorina Cezara
Tarmure, Simina
Orasan, Olga Hilda
Fodor, Adriana
Negrean, Vasile
Pop, Dana
Zdrenghea, Dumitru
Login, Cezar
Tiperciuc, Brandusa
Cozma, Angela
author_sort Sitar-Taut, Adela-Viviana
collection PubMed
description Background: Diabetes and obesity are increasingly significant public health issues. The aim of this study was to evaluate the relationship between adipocytokines (leptin, ghrelin, and chemerin), inflammation (sVCAM1—soluble vascular adhesion molecule 1, sICAM1—soluble intercellular adhesion molecule 1), and insulin resistance in the presence of obesity and diabetes mellitus. Methods: 88 subjects, with a mean age of 61.96 ± 10.15 years, 75% of whom were women, were evaluated (in order to consider different associations between obesity and diabetes, subjects were categorized into four groups). Results: Overall, we found significant correlations between sICAM1-sVCAM1 rho = 0.426 and ghrelin-chemerin rho = −0.224. In the obesity + diabetes group, leptin correlated with sICAM1 rho = 0.786, and sVCAM1 negatively with glycemia/insulin rho = −0.85. Significant differences were found between the groups regarding sVCAM1 (p = 0.0134), leptin (p = 0.0265) and all insulin resistance scores, with differences influenced by the subjects’ gender. In conclusion, although there are currently many unknown aspects of the release and the role of various adipokines, in particular chemerin, its implication in early glucose metabolism dysregulation disorders seems very likely.
format Online
Article
Text
id pubmed-7564772
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75647722020-10-26 Diabetes and Obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and Insulin Resistance Sitar-Taut, Adela-Viviana Coste, Sorina Cezara Tarmure, Simina Orasan, Olga Hilda Fodor, Adriana Negrean, Vasile Pop, Dana Zdrenghea, Dumitru Login, Cezar Tiperciuc, Brandusa Cozma, Angela J Clin Med Article Background: Diabetes and obesity are increasingly significant public health issues. The aim of this study was to evaluate the relationship between adipocytokines (leptin, ghrelin, and chemerin), inflammation (sVCAM1—soluble vascular adhesion molecule 1, sICAM1—soluble intercellular adhesion molecule 1), and insulin resistance in the presence of obesity and diabetes mellitus. Methods: 88 subjects, with a mean age of 61.96 ± 10.15 years, 75% of whom were women, were evaluated (in order to consider different associations between obesity and diabetes, subjects were categorized into four groups). Results: Overall, we found significant correlations between sICAM1-sVCAM1 rho = 0.426 and ghrelin-chemerin rho = −0.224. In the obesity + diabetes group, leptin correlated with sICAM1 rho = 0.786, and sVCAM1 negatively with glycemia/insulin rho = −0.85. Significant differences were found between the groups regarding sVCAM1 (p = 0.0134), leptin (p = 0.0265) and all insulin resistance scores, with differences influenced by the subjects’ gender. In conclusion, although there are currently many unknown aspects of the release and the role of various adipokines, in particular chemerin, its implication in early glucose metabolism dysregulation disorders seems very likely. MDPI 2020-08-26 /pmc/articles/PMC7564772/ /pubmed/32858998 http://dx.doi.org/10.3390/jcm9092767 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sitar-Taut, Adela-Viviana
Coste, Sorina Cezara
Tarmure, Simina
Orasan, Olga Hilda
Fodor, Adriana
Negrean, Vasile
Pop, Dana
Zdrenghea, Dumitru
Login, Cezar
Tiperciuc, Brandusa
Cozma, Angela
Diabetes and Obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and Insulin Resistance
title Diabetes and Obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and Insulin Resistance
title_full Diabetes and Obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and Insulin Resistance
title_fullStr Diabetes and Obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and Insulin Resistance
title_full_unstemmed Diabetes and Obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and Insulin Resistance
title_short Diabetes and Obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and Insulin Resistance
title_sort diabetes and obesity—cumulative or complementary effects on adipokines, inflammation, and insulin resistance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564772/
https://www.ncbi.nlm.nih.gov/pubmed/32858998
http://dx.doi.org/10.3390/jcm9092767
work_keys_str_mv AT sitartautadelaviviana diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance
AT costesorinacezara diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance
AT tarmuresimina diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance
AT orasanolgahilda diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance
AT fodoradriana diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance
AT negreanvasile diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance
AT popdana diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance
AT zdrengheadumitru diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance
AT logincezar diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance
AT tiperciucbrandusa diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance
AT cozmaangela diabetesandobesitycumulativeorcomplementaryeffectsonadipokinesinflammationandinsulinresistance